Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Sales | 44,390 | 43,799 | 18,597 | 22,081 | 19,571 |
| Gross Profit | 44,390 | 43,799 | 18,597 | 22,081 | 19,571 |
| Operating Expenses | 76,790 | 63,054 | 43,141 | 48,581 | 40,301 |
| Operating Income | -32,400 | -19,255 | -24,544 | -26,500 | -20,730 |
| Interest Expense | 680 | 576 | 462 | 481 | 439 |
| Other Income | 0 | 0 | -14,999 | 5,453 | 3,574 |
| Pre-tax Income | -33,080 | -19,831 | -40,005 | -21,528 | -17,595 |
| Net Income Continuous | -33,086 | -19,831 | -24,967 | -21,528 | -17,595 |
| Net Income | $-33,080 | $-19,831 | $-40,005 | $-21,528 | $-17,595 |
| EPS Basic Total Ops | -0.66 | -0.41 | -1.07 | -0.63 | -0.56 |
| EPS Basic Continuous Ops | -0.65 | -0.41 | -0.66 | -0.62 | -0.56 |
| EPS Diluted Total Ops | -0.66 | -0.41 | -1.07 | -0.63 | -0.56 |
| EPS Diluted Continuous Ops | -0.65 | -0.41 | -0.66 | -0.62 | -0.56 |
| EBITDA(a) | $-27,880 | $-15,667 | $-21,384 | $-22,790 | $-17,245 |